Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Polycythemia × Hydroxyurea × Myeloid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycythemia Vera 8 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Leukemia, Myeloid, Chronic-Phase 7 Leukemia 7 Myelodysplastic Syndromes 4 Leukemia, Myeloid, Acute 4 Myeloproliferative Disorders 3 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3 Primary Myelofibrosis 2 Myelodysplastic-Myeloproliferative Diseases 2 Leukemia, Myelomonocytic, Chronic 2 Congenital Abnormalities 2 Thrombosis 1 Thrombocytosis 1 Thrombocythemia, Essential 1 Polycythemia 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Monocytic, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Erythroblastic, Acute 1 Bone Marrow Neoplasms 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

imetelstat 1 Vorinostat 1 Spectroscopy, Near-Infrared 1 Phlebotomy 1 N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide 1 Hydroxyurea 1 Histone Deacetylase Inhibitors 1 GRN163L peptide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01645124 2012-07-20

CYTO-PV

Consorzio Mario Negri Sud

Phase 3 Terminated

Polycythemia, Polycythemia Vera, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡